Sentynl Therapeutics, Inc.

Sentynl Therapeutics, Inc. is a San Diego-based specialty pharmaceutical company dedicated to providing healthcare professionals with treatment solutions that enable them to meet the needs of individual patients. With a strong focus on product development, Sentynl sources unique, effective products designed to treat pain and other central nervous system (CNS) conditions.

Sentynl's excellent management team has led, founded, and funded multiple biopharmaceutical companies for over 20 years. Their team is thoroughly trained to uphold the highest industry standards of ethics and compliance.

For more information on Sentynl Therapeutics, be sure to visit their website linked above.

Sentynl is seeking pharmaceutical licensing and acquisition opportunities within the specialty pharmaceutical space.

Target acquisition opportunities for Sentynlinclude late stage development programs and currently marketed specialty products.

We are always looking for exceptional candidates to join our growing team.

Please contact us to explore partnership and licensing opportunities.

-Track record of successful partnerships, with demonstrated value creation for partners.

-Founded by industry veterans with deep expertise, strategic vision and operational excellence.

-Strong financial backing and ability to move quickly to execute transactions.

Sentynl Therapeutics seeks to provide professionals in healthcare with solutions for treatment that enables them in meeting the needs of individual patients. Sentynlhas a highly-experienced and knowledgeable management team who have previously worked to build several successful pharmaceutical companies before joining the team at Sentynl. With a commercial focus, they are looking to source a variety of differentiated and effective products across a wide spread of the therapeutic spectrum. Engaged and enthusiastic, the entire team is committed to the highest of ethical standards and compliance with all applicable laws, regulation, and industry guidelines.

In order to complement its existing product portfolio and further leverage its commercial infrastructure, Sentynl currently seeks product licensing and acquisition opportunities. Target acquisition opportunities include late stage development programs and marketed products in specialty pharmaceuticals. You can visit http://www.sentynl.com/business-development/ for more information or contact them at [email protected]. For more information about Abstral®, visit http://www.sentynl.com/abstral/.